Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Cytokinetics, Incorporated(CYTK) | 431,693 | 431,693 | 0 | $12.72M | $36.04M | 12.47% | +$23.32M |
| Acadia Pharmaceuticals Inc | 556,553 | 769,653 | +213,100 | $11.60M | $24.10M | 8.34% | +$12.50M |
| Amicus Therapeutics Inc COM | 1,489,025 | 1,489,025 | 0 | $18.11M | $21.13M | 7.31% | +$3.02M |
| Arvinas, Inc.(ARVN) | 504,700 | 504,700 | 0 | $9.91M | $20.77M | 7.19% | +$10.86M |
| Ascendis Pharma A/SADR(ASND) | 163,772 | 163,772 | 0 | $15.34M | $20.63M | 7.13% | +$5.29M |
| Springworks Therapeutics Inc | 556,928 | 556,928 | 0 | $12.88M | $20.33M | 7.03% | +$7.45M |
| Home Plate Acquisition CorpW EXP 09 30 202 | 690,000 | 331,416 | -358,584 | $0 | $20.01M | 6.92% | +$20.01M |
| Lakefront Biotherapeutics NVADR(LKFT) | 458,659 | 458,659 | 0 | $15.85M | $18.64M | 6.45% | +$2.80M |
| Revolution Medicines, Inc.(RVMD) | 427,000 | 617,100 | +190,100 | $11.82M | $17.70M | 6.12% | +$5.88M |
| Liberty Broadband CorpCOM SER C | 0 | 184,460 | +184,460 | $0 | $14.87M | 5.14% | +$14.87M |
| Relay Therapeutics, Inc.(RLAY) | 870,870 | 1,317,870 | +447,000 | $7.32M | $14.51M | 5.02% | +$7.19M |
| Morphic Holding Inc | 325,356 | 496,856 | +171,500 | $7.45M | $14.35M | 4.96% | +$6.90M |
| Sarepta Therapeutics, Inc.(SRPT) | 145,357 | 145,357 | 0 | $17.62M | $14.02M | 4.85% | -$3.60M |
| Travere Therapeutics, Inc.(TVTX) | 895,821 | 1,435,321 | +539,500 | $8.01M | $12.90M | 4.46% | +$4.89M |
| Prothena Corp PlcSHS SHS | 349,300 | 349,300 | 0 | $16.85M | $12.69M | 4.39% | -$4.16M |
| Solid Biosciences Inc | 961,251 | 961,251 | 0 | $2.42M | $5.90M | 2.04% | +$3.48M |
| Calidi Biotherapeutics Inc | 125,000 | 125,000 | 0 | $415.6K | $188.8K | 0.07% | -$226.9K |
| Churchill Capital Corp ViiW EXP 02 29 202 | 548,000 | 548,000 | 0 | $168.8K | $71.3K | 0.02% | -$97.5K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 331,416 | 895,000 | +563,584 | $18.89M | $62.7K | 0.02% | -$18.83M |
| Concord Acquisition Corp IIW EXP 99 99 999(CNDA) | 408,333 | 408,333 | 0 | $42.6K | $53.1K | 0.02% | +$10.5K |
| Calidi Biotherapeutics IncW EXP 03 14 202 | 655,200 | 655,200 | 0 | $144.1K | $32.8K | 0.01% | -$111.4K |
| Ross Acquisition Corp IiW EXP 02 01 202 | 439,666 | 439,666 | 0 | $49.0K | $24.6K | 0.01% | -$24.4K |
| Compass Digital Acquisition CorpW EXP 09 29 202 | 459,906 | 459,906 | 0 | $101.3K | $22.3K | 0.01% | -$79.0K |
| Marblegate Acquisition CorpW EXP 08 31 202 | 735,000 | 735,000 | 0 | $13.5K | $22.1K | 0.01% | +$8.5K |
| Swiftmerge Acquisition CorpW EXP 12 13 202 | 490,000 | 490,000 | 0 | $34.6K | $20.1K | 0.01% | -$14.5K |
| Ys Biopharma Co LtdW EXP 03 15 202 | 489,999 | 489,999 | 0 | $17.1K | $13.3K | 0.00% | -$3.9K |
| ARES ACQUISITION CORP*W EXP 02/02/202 | 504,706 | 0 | -504,706 | $333.6K | $0 | — | -$333.6K |
| BRIDGETOWN HOLDINGS LTD*W EXP 09/30/202 | 895,000 | 0 | -895,000 | $304.3K | $0 | — | -$304.3K |
| CEREVEL THERAPEUTICS HLDNG ICOM | 563,345 | 0 | -563,345 | $12.30M | $0 | — | -$12.30M |
| CHURCHILL CAPITAL CORP V*W EXP 10/29/202 | 612,000 | 0 | -612,000 | $0 | $0 | — | $0 |
| CHURCHILL CAPITAL CORP VI*W EXP 02/17/202 | 540,000 | 0 | -540,000 | $86.4K | $0 | — | -$86.4K |